<code id='AF329C1A24'></code><style id='AF329C1A24'></style>
    • <acronym id='AF329C1A24'></acronym>
      <center id='AF329C1A24'><center id='AF329C1A24'><tfoot id='AF329C1A24'></tfoot></center><abbr id='AF329C1A24'><dir id='AF329C1A24'><tfoot id='AF329C1A24'></tfoot><noframes id='AF329C1A24'>

    • <optgroup id='AF329C1A24'><strike id='AF329C1A24'><sup id='AF329C1A24'></sup></strike><code id='AF329C1A24'></code></optgroup>
        1. <b id='AF329C1A24'><label id='AF329C1A24'><select id='AF329C1A24'><dt id='AF329C1A24'><span id='AF329C1A24'></span></dt></select></label></b><u id='AF329C1A24'></u>
          <i id='AF329C1A24'><strike id='AF329C1A24'><tt id='AF329C1A24'><pre id='AF329C1A24'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:14453
          Alastair Grant/AP

          LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

          The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met. 

          advertisement

          AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date
          Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

          4:15FormerPresidentDonaldTrumpspeaksbeforeheboardshisplaneatRonaldReaganWashingtonNationalAirport,Au

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          After a drawn out lobbying fight, ARPA

          Afteradrawn-outlobbyingfight,ARPA-Hchoseitsheadquarters:ahubandspokesmodel,withthreecentrallocations